Novo Nordisk A/S — FDA Facility Profile

FEI 3009341839

Novo Nordisk A/S is an FDA-inspected facility (FEI 3009341839) located in Soborg, DK. RegDataLab tracks 6 FDA inspections at this facility.

Reviewing Novo Nordisk A/S as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Novo Nordisk A/S yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Jan 23, 2026: No Action Indicated (NAI)
Inspections on record
6 (2 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jan 23, 2026No Action Indicated (NAI)No citations listed
Nov 17, 2023No Action Indicated (NAI)No citations listed
Nov 10, 2017No Action Indicated (NAI)No citations listed
Jun 15, 2017No Action Indicated (NAI)No citations listed
May 3, 2012Voluntary Action Indicated (VAI)General responsibilities of sponsors (21 CFR 312.50)
Apr 30, 2012Voluntary Action Indicated (VAI)Investigator non-compliance (21 CFR 312.56(b))
General responsibilities of sponsors (21 CFR 312.50)

Facility details

Company
Novo Nordisk A/S
Location
Soborg (DK)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.